Shares of Inovio Pharmaceuticals Inc. INO slid 4.78% to $1.99 Monday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 1.20% ...
The evolution of protocol management within eQMS represents another significant advance in clinical trials. Version control ...
Alembic's revenue from operations rose to Rs 1,692.74 crore in Q3FY25, a 3.8 per cent Y-o-Y increase from Rs 1,630.57 crore ...
Today, companies including Religare Enterprises, Gland Pharma, Fortis Malar Hospitals, Aditya Birla Capital, Alembic Pharma, ...
In the fast-paced pharmaceutical industry, managing product returns efficiently has become a cornerstone of operational ...
In the corresponding quarter of the previous fiscal, Alembic Pharmaceuticals posted a net profit of ₹180.4 crore. The company ...
Sun Pharmaceutical Industries Ltd. 524715 shares inched down 0.16% to 1,739.95 Indian rupees Monday, on what proved to be an all-around grim trading session for the stock market, with the BSE SENSEX ...
The company posted revenue from operations at Rs 1,692.74 crore, up 3.81 per cent as against Rs 1,630.57 crore during the ...
19hon MSN
Alembic Pharmaceuticals reported a 23.29% decline in Q3 FY25 net profit at ₹138.42 crore, despite a 3.81% revenue increase to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback